Last reviewed · How we verify
NCT06034327: EUCALYPTUS
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
NA trial testing Single vision, impact-resistant spectacle lenses; Test Arm in Myopia in 150 participants. Currently enrolling.
31 January 2027
Quick facts
| Lead sponsor | SightGlass Vision, Inc. |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 18 September 2023 |
| Primary completion | 31 January 2027 |
| Estimated completion | 31 March 2027 |
| Sites | 14 locations across United States |
Drugs / interventions tested
- Single vision, impact-resistant spectacle lenses; Test Arm
- Single vision, impact-resistant spectacle lenses; Control Arm
Conditions studied
- Myopia — all drugs for Myopia →
- Juvenile Myopia — all drugs for Juvenile Myopia →
- Myopia Progression — all drugs for Myopia Progression →
Sponsor
SightGlass Vision, Inc.
Who can join
Adults 6 to 8, any sex, with Myopia or Juvenile Myopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will be used to predict the 3-year treatment efficacy. This is a randomized, controlled (1:1), multisite, subject- and observer-masked, 2-arm parallel group study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06034327
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myopia
Currently open trials in the same condition.
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
- NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
- NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
- NCT07229365 — Children's Viewing Behavior · NA · recruiting
Other SightGlass Vision, Inc. trials
Trials by the same sponsor.
- NCT07229352 — Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses · NA · not yet recruiting
- NCT07229365 — Children's Viewing Behavior · NA · recruiting
- NCT07008001 — Assessment of DOT Spectacles in Chinese Children Extension · NA · recruiting
- NCT05893979 — Myopia Control Spectacle Lens Cessation Study · NA · active not recruiting
- NCT05562622 — Assessment of DOT Spectacles in Chinese Children · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06034327 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SightGlass Vision, Inc.
- Last refreshed: 29 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06034327.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing